Sergii Strelchuk is an Associate Professor of Computer Science at the University of Oxford, specializing in quantum computing and its applications. His research sits at the intersection of quantum information theory, computer science, and bioinformatics, with a focus on developing quantum algorithms for practical problems in genomics and beyond. Professor Strelchuk's primary research interests include quantum algorithms and their applications (particularly in bioinformatics), classical simulation methods for quantum computation, quantum complexity theory, and quantum learning theory. His work bridges theoretical quantum computing with practical applications, especially in the emerging field of quantum genomics and pangenomics, with significant implications for understanding human and pathogen genomes. His recent publications demonstrate a strong focus on applying quantum computing techniques to genomic data analysis, developing efficient fermion-qubit mappings for quantum simulation, and exploring fundamental aspects of quantum complexity theory. His research shows a clear trajectory toward making quantum computing practically applicable to biological data analysis and advancing our theoretical understanding of quantum computational models. Among his notable scientific achievements are: Royal Society University Research Fellow Leverhulme Early Career Fellow John and Delia Agar Research Fellow Professor Strelchuk leads several significant research projects including the Wellcome Leap "Human and Pathogen Quantum Pangenomics" project (2023-2026), which recently entered Phase 3 in April 2025, the EPSRC "Structure and symmetry in quantum verification" grant (2023-2025), and the "Quantum Algorithms for Quantum Field Theory" project (2022-2025). His research has attracted substantial funding for quantum computing applications in genomics. His work has received significant attention in both academic and popular science media, including coverage in Quanta Magazine and collaborations with institutions like the Sanger Institute to tackle complex genomic challenges using quantum computing approaches, with recent publicity about his leadership in the final phase of the Wellcome Leap-funded quantum pangenomics project.









